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Introduction
Pemphigus vulgaris (PV) is a chronic, rare but potential-
ly life-threatening bullous disease of the mucous mem-
branes and skin with established autoimmune nature. PV 
can affect all races, however the epidemiological studies 
report the highest prevalence of PV in people of Jewish 
ancestry and Mediterranean area. The prevalence of PV 
is 30/100 000 and annual incidence rate varies from 1 to 5 
in 100 000 in different investigations carried out in Iran.1,2 
The most common presenting sign of PV are persistent 
painful mucosal erosions, especially of the oral cavity 
which may be the only/sole sign of the disease preced-
ing the development of bullous skin lesions for weeks to 
months. The flaccid blisters in oral cavity are very fragile, 
rupture easily, leaving painful erosions. PV oral lesions 
may be extremely painful. The severe pain of these lesions 
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Abstract
Introduction: Pemphigus vulgaris (PV) is a chronic, serious autoimmune mucocutaneous 
bullous disease. Oral lesions in PV may be extremely painful. This pain may adversely affect 
the patients’ oral intake and quality of life. This before-after clinical trial was designed to 
assess the pain relieving effects of single session of non-ablative, non-thermal CO2 laser 
therapy (NTCLT) in oral lesions of PV. 
Methods: Fifty painful oral lesions of fourteen patients with PV were illuminated by CO2 
laser (power: 1 W, scanning the lesions with rapid circular motion of the handpiece) 
passing through a thick layer of transparent gel with high water content. The pain severity 
of the oral lesions was reported by the patients up to the fourth postoperative day. They 
were also asked to continue their existing systemic treatment during the course of this study 
as a precondition for the participation. 
Results: The severity of contact and non-stimulate (non-contact) pain declined immediately 
and significantly after NTCLT (P < 0.001). The pain relieving effect was sustained during the 
four successive days of follow-up. The procedure was pain free and no kind of analgesics 
was required. Following NTCLT, there were no visible thermal complications such as 
destruction, ablation or irritation of the oral lesions.
Conclusion: The results of the trial proposed that single session of NTCLT could 
immediately and significantly relieve pain in oral lesions of PV, without any visible thermal 
complications. 
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can adversely affect the nutritional intake and quality of 
life of the patients.3,4
The mortality rate of PV has declined considerably after 
treatment with high doses of systemic corticosteroids in 
combination with adjuvant immunosuppressive drugs. 
Since PV is severe and life threatening, it is rational that 
the majority of investigations have focused on improving 
the therapeutic options for suppression and remission of 
the disease and rarely to the pain management of the oral 
lesions.5 However, the considerable delay in remission of 
the oral lesions allows plenty of opportunities for compli-
cations such as malnutrition and dehydration to develop, 
due to the pain of the oral lesions.5 In addition, the pain 
of the oral lesions may interfere with taking oral medica-
tions necessary for the control of the disease. Therefore, it 
seems necessary to obtain novel analgesic options for oral 
lesions of PV during conventional systemic treatment. 
Low-level laser therapy (LLLT) or laser phototherapy is a 
fast-growing technology mainly applied clinically for pain 
relief, accelerating wound healing and anti-inflammatory 
effects for decades.6
For decades, CO2 laser has served as a helpful surgical ap-
pliance for incision, excision, vaporization and coagula-
tion. Recently, some investigators have reported the ben-
efits of CO2 laser application in a non-ablative, non-ther-
mal manner as a low level (low intensity, photothera-
peutic) laser for significant and immediate pain relief in 
some oral lesions with no thermal complications. In these 
studies, irradiation of painful oral lesions was performed 
through a layer of transparent high water containing gel 
with no analgesic properties in order to prevent thermal 
damage.
The painful oral lesions were illuminated through a lay-
er of transparent gel with high water content in order to 
reduce the beam absorption by the lesion and prevention 
of tissue injury. The patients reported significant and im-
mediate pain relief after laser treatment. The process was 
pain free with no need to anesthesia. No kind of thermal 
complications were observed after laser treatment.7-11 This 
non-destructive technique was initially called non-abla-
tive CO2 laser therapy (NACLT) and non-thermal CO2 
laser therapy (NTCLT) afterwards. The results of ther-
mometry and powermetery confirmed the low level pho-
totherapeutic character of NTCLT.9 
NTCLT has been used for immediate and significant pain 
relief in some painful oral lesions.9,10,12,13 The study being 
reported in this paper was designed to evaluate the NT-
CLT pain relieving effects on PV oral lesions.
Methods 
Study Design
This study was designed as a before-after open study. All 
of the referred patients were evaluated before inclusion in 
the study. Before taking the informed consent, the entire 
process used in the study and its investigational character 
were explained to all of the patients. The patients were 
well-advised that this procedure might have an impact 
only on the reduction of the pain caused by the lesions. 
They were also asked to continue their existing systemic 
treatment during the course of this study as a precondi-
tion for the participation. 
Patient Selection
The inclusion criteria were: presence of pathogonomonic 
H&E histologic findings and positive direct immunofluo-
rescence (DIF) test for PV supporting clinical features, ex-
istence of painful oral pemphigus lesions interfering with 
eating, continuation of the systemic treatment for PV dis-
ease. Patients with age less than 18, photosensitivity and 
current pregnancy or lactation were excluded.
Study Procedure
Before laser irradiation, the lesion and its surrounding 
were covered with a thick (3-4 mm) layer of a transparent 
gel with high water (87.5%) content (Abzar Darman Co., 
Iran). The patient and surgical staff used appropriate pro-
tective eye glasses during the treatment.
The CO2 laser (10 600 nm; Lancet-2, Russia) was operated 
at 1 W power, in a continuous defocused mode, 5-6 mm 
distant from the surface of the gel while scanning rapidly 
over the lesion with a circular motion. In each pass, the 
laser energy was delivered to a circle area of the lesion 
(nearly1cm diameter) for 5 seconds and repeated imme-
diately if the contact pain of the lesion persisted. The gel 
was gently wiped between the passes, and a new layer of 
gel was placed on the lesion to prevent from decreasing 
the water content of gel and tissue damage. The procedure 
was pain free and no kind of anesthesia was needed. 
Assessments
The patients graded and recorded the contact and 
non-stimulate (non-contact) pain severity of their lesions 
before NTCLT, immediately after treatment and at 4, 8, 
12, 24 hours post-operatively and then daily for up to 4 
successive days. Patients were visited by the evaluator 
physician on daily basis in search for any kind of adverse 
effects. 
Statistical Analysis 
Data regarding the patients’ responses were analyzed by 
SPSS version 13. The results were expressed as mean ± 
standard deviation (SD). Statistical significance was test-
ed with Student’s t test for paired samples and repeated 
measurement analysis. P < 0.05 was regarded as statistical-
ly significant.
Results 
Fifty painful oral lesions of fourteen patients with PV re-
cruited in the trial. The age range of patients was 33-86 
years (mean, 47.7 ± 14.7 years). The means of the base-
line visual analogue scale (VAS) pain scores for non-stim-
ulated (non-contact) and contact pain of the lesions 
were 4 ± 1.6 and 7.5 ± 1.6 respectively. Immediately after 
NTCLT, the scores for non-stimulate (non contact) and 
contact pain decreased dramatically to zero in nearly 
all patients (P < 0.001), and continued until the end of 
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the follow up periods with a mean range of 0.24 to 0.64 
for non-stimulate pain score and 0.56 to 1.6 for contact 
pain score. (Figures 1 and 2) These differences between 
the mean scores of both non-stimulate and contact pain 
were also statistically significant throughout the follow 
up periods in comparison with the baseline pain scores 
(P < 0.001). The laser procedure was painless and no kind 
of anesthesia was needed. None of the patients report-
ed warmth sensation in oral cavity during NTCLT. The 
evaluator physician recorded no visible thermal compli-
cations such as burn, destruction, ulceration or irritation 
of the lesions after NTCLT. At the end of the follow up 
sessions, the patients had no sensory loss in laser treated 
areas. There was no plume formation during NTCLT.
Discussion
This before-after clinical trial suggested that single ses-
sion of NTCLT as a photobiomodulative procedure can 
be used in order to relieve pain immediately and dramati-
cally in oral lesions of PV. The laser protocol was painless 
with no need to anesthesia. There was no aggravation of 
the lesions or visible thermal side effects following the ap-
plication of NTCLT. To the best of authors’ knowledge, 
this is the first study to report the pain relieving effects of 
non-thermal CO2 laser application in oral lesions of PV. 
LLLT (also known as “low intensity laser therapy, LILT,” 
“low power laser therapy,” “laser phototherapy,” “soft la-
ser therapy,” “cold laser therapy,” “photobiostimulation,” 
“photobiomodulation,” “non-ablative irradiation,” etc) is a 
fast-growing technology used for pain relief, accelerating 
wound healing and anti-inflammatory effects.6 Today, the 
applications of laser phototherapy have expanded to in-
clude serious diseases, e.g. myocardial infarction, stroke, 
traumatic and degenerative brain disorders diseases. La-
ser phototherapy is increasingly recognized as a valuable 
and safe option for pain management.
It should be noticed that in addition to the traditional 
low power phototherapeutic lasers (such as He-Ne laser, 
GaAs, GaAlAs and InGaAIP lasers ) by some consider-
ations, surgical lasers can also be used as low level lasers, 
for example; ruby laser 694 nm, CO2 laser 10 600 nm, 
and neodymium-doped yttrium aluminum garnet (Nd: 
YAG) laser 1064 nm all in defocused mode can be applied 
for laser phototherapy. As Tuner once said “When high 
power lasers are used for biomodulation, one only needs 
to make the beam wide enough not to burn. An alterna-
tive is to scan rapidly over the lesion with a narrow beam. 
Therefore, the power density or average power is kept low 
enough to avoid burning, and their incident energy and 
power density are set within the low intensity laser ther-
apy range.” The interesting experiment of Endre Mester 
with a low-powered ruby (694 nm) laser irradiation on 
the shaved areas of the back of the mice and faster regrow-
ing of the hairs can be considered as the first demonstra-
tion of photobiostimulation by a surgical laser.14,15 
With the purpose of application of the CO2 laser as a low 
level, photobiomodulative laser for NTCLT, the CO2 laser 
energy should be delivered not only by a de-focused hand 
piece moving in a circular manner in order to scan rapidly 
the whole surface of the lesion, but also through a thick 
layer of high water content, transparent gel capable of re-
ducing the beam absorption by the tissue and prevent un-
wanted tissue burn or injury. By these considerations, the 
final laser power output after irradiation through the gel 
drops considerably by a factor of 200-500, and CO2 laser 
can be used as a low level, phototherapeutic laser without 
any visible thermal side effects.9
Recently, investigators have demonstrated the benefits of 
CO2 laser application in non- destructive manner for pain 
reduction of some oral lesions.7-9,16 In order to evaluate the 
pain relieving effects of CO2 laser beam in graft-versus-
host-disease (GVHD), Elad et al kept the surface of the 
lesions wet during irradiation to prevent mucosal dam-
age. They used CO2 laser treatment for four patients with 
oral GVHD within 17 sessions.7 The CO2 laser (power: 1 
W, 2-3 s/1 mm2) was applied over mucosal lesions. Since 
the procedure was painless, anesthesia was not needed. 
The average VAS pain scores before, during, and immedi-
ately after treatment were 8.09, 3.47, and 4.88 respectively. 
There were not any visible complications following CO2 
laser irradiation.7 
In another case report, oral aphthous ulcers of two pa-
tients were treated with CO2 laser (power: 1.0-1.5 W, with 
a defocused hand piece for 5 seconds) through a thin film 
Figure 1. Mean Non-contact Pain Scores (VAS) in Follow up 
Sessions
Figure 2. Mean Contact Pain Scores (VAS) in Follow up Sessions
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of Elmex gel (a transparent gel with high water content). 
Immediately after laser irradiation, the patients reported 
pain relief without any visible complication. The proce-
dure was free of pain and no kind of anesthesia was not 
needed.8
In another randomized control trial (RCT), the pain reliv-
ing effects of single session of non ablative, non thermal 
CO2 laser irradiation was evaluated in minor recurrent 
aphthous stomatitis (miRAS) as a prototype of painful 
oral lesions.9 In this RCT the investigators randomized 
30 minor aphthous ulcers of 15 patients in to laser and 
placebo groups. Before laser therapy, a thick (3-4 mm) 
layer of high water content gel (87.5% water) with no an-
esthetic properties was placed on both the placebo and la-
ser lesions. The laser group lesions were illuminated with 
CO2 laser (power: 1 W, in de-focused continuous mode, 
scanning rapidly over the lesion for 5-10 seconds). This 
RCT demonstrated that immediately after single session 
of non-ablative CO2 laser treatment, the pain of the le-
sions relieved significantly (P < 0.001), so that the patients 
in laser group could eat and drink easily immediately after 
treatment. This pain relieving effect was sustained during 
the four days follow-up periods. The procedure was not 
painful and no kind of anesthesia was required. After 
laser therapy, no visible thermal complications were ob-
served such as burn, destruction, ulceration, or irritation 
of the lesions.9
Another pilot RCT demonstrated a favorable analgesic 
effect of NTCLT randomized 10 major aphthous ulcers 
of 5 patients into laser and placebo groups. The ulcers in 
laser group received the same laser protocol of Zand et 
al10; however according to the larger size of the major aph-
thous ulcers, more than one pass of NTCLT were applied. 
The results of this pilot study proposed that application 
of only one session of NTCLT could provide immediate 
and significant pain relief in major oral aphthous ulcers 
(P < 0.001) with no visible thermal complications so that 
the differentiation of pictures of before/after laser lesions 
was not easy.
Prasad and colleagues performed an RCT on 25 patients 
with 50 minor aphthous ulcers. In laser group, the lesions 
were illuminated through a layer of high water (90%) con-
tent gel with CO2 laser (10600 nm, power: 0.7 W, contin-
uous mode with a defocused hand piece for 5-8 seconds). 
This protocol provided immediate analgesic effect which 
sustained over 24 hours.11
After these primary evidences of analgesic properties of 
NTCLT in recurrent aphthous stomatitis, we decided to 
appraise the analgesic effects of single session of NTCLT 
in painful oral lesions of PV. Fourteen patients with 50 
areas of PV, treated with conventional systemic treatment 
of the disease, were included in the study. The results of 
this before-after clinical trial proposed that application of 
single session of NTCLT could provide immediate and 
significant pain relief in oral lesions of PV (P < 0.001) with 
no visible thermal adverse effects or irritation of the le-
sions. The pain relieving effect continued during the four 
days follow-up periods. None of the patients reported 
warmth sensation in their oral cavity during NTCLT. The 
NTCLT procedure was painless and no anesthetic agent 
was needed. There was no tissue ablation or plume for-
mation during the process, which increased the safety of 
the procedure for the surgeon and operating room staff. 
In the review of literature, there were few reports on the 
application of other laser systems for pain reduction of 
PV oral lesions. In a case report, the investigators used 
LLLT as an adjuvant in two cases of PV. The patients had 
received systemic corticosteroid and dapsone. Their oral 
lesions were irradiated with diode laser (660 nm, 100 mW 
output power, 2 J per point, fluence: 35 J/cm2 per point, 
time: 20 seconds per point). Immediately after the first 
session of LLLT, the patients reported approximately 70% 
oral pain reduction. Complete pain relief was reported af-
ter the third sessions.17 
In another case report, Bhardwaj and colleagues reported 
the benefits of CO2 laser application, as a classic surgi-
cal laser in two cases of painful recalcitrant oral PV.18 The 
patients had received systemic corticosteroid and cyclo-
phosphamide for 6-8 months. The painful lesions were 
irradiated at 1.0-1.5 W in a defocused manner for 5-10 
seconds. They reported pain relief and improved wound 
healing after laser irradiation. In this study, the laser pow-
er used was low, however it was in the range of thermal, 
surgical lasers, and the lesions were ablated and coagulat-
ed. Certainly this procedure is quite different from NT-
CLT as a low intensity (photobiomodulative) laser pro-
cedure. It seems that the analgesic effects of surgical CO2 
laser in the study of Bhardwaj et al can be explained with 
the concurrent photobiomodulative effects of CO2 sur-
gery. The same concept that Kaplan et al stated in 1996.19
It should be noticed that some researchers who used the 
conventional, thermal effects of CO2 laser in surgery (for 
cutting, ablation, destruction and coagulation of the le-
sions) reported less postoperative pain following CO2 laser 
surgery.19-22 Kaplan et al explained the lower postoperative 
pain experienced with CO2 laser surgery to the concur-
rent low level laser phototherapeutic (photobiomodula-
tive) effects of high power CO2 laser surgery.
14,19,23 Kaplan 
et al stated that: “Laser surgery and low level laser therapy 
should be regarded as two sides of the same coin.”14,19,23 In 
fact, the analgesic effects of thermal CO2 laser treatment 
in Bhardwaj study can be explained by the concurrent low 
power laser therapeutic (photobiomodulative) effects of 
CO2 laser surgery.  
Certainly, NTCLT as a non-thermal, low intensity (pho-
tobiomodulative) laser procedure is quite different from 
using surgical, thermal CO2 laser irradiation in Bhardwaj 
study. As discussed above, following NTCLT, there were 
no visible adverse effects of thermal complications such 
as destruction, ulceration or even erythema.
Since PV is a serious and life threatening disease with-
out appropriate systemic treatment, the patients should 
be informed that application of NTCLT cannot substitute 
the systemic therapy of the disease, as we instructed our 
patients to comply with their prescribed medical regimen. 
In order to clarify the mechanisms of the pain relieving 
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effects of NTCLT, powermetery and thermometery were 
performed in our previous studies.9 These studies con-
firmed the low power, non-thermal nature of applied CO2 
laser in this laser procedure. This technique was initially 
called NACLT, however after demonstrating the non-ther-
mal nature of the technique, it was called NTCLT to avoid 
misinterpretation with high power fractional non- abla-
tive CO2 lasers used for skin rejuvenation. In fact, NTCLT 
as a non-thermal, low intensity (biomodulative) laser pro-
tocol is not only quite different from conventional high 
power CO2 lasers irradiation, but also should not be mis-
interpreted with fractional non-ablative CO2 lasers, which 
are high power, thermal lasers too.
Since the pain relieving effect of NTCLT is immediate, we 
suppose that physiological neural changes such as block-
age of action potential generation and slowing the con-
duction velocity of nociceptive signals in small diameter, 
unmyelinated C and thinly myelinated A δ fibers might 
participate in this pain relieving effect. Morphological 
changes of the nerve endings especially reversible varicos-
ity formation might be another hypothesis in this field. 
Nerve endings destruction is less likely to be provoked by 
NTCLT, because, even the investigators who applied CO2 
laser as a classical surgical instrument, reported no statis-
tically significant difference between the number of intact 
peripheral nerves of laser-treated sites and sites treated 
with scalpel or electro cautery.24 We do not know wheth-
er the other presumed mechanisms, such as increase in 
β-endorphin synthesis and release,25,26 blockage of ace-
tylcholine,26 reduction of bradykinin and prostaglandins 
synthesis,27 suppression of Substance P,28 changes in nitric 
oxide29 and other chemicals- proposed to play at least a 
part in pain relief of low level phototherapeutic lasers- 
participate in analgesic effect of NTCLT, or not. Further 
basic studies are needed to clarify the real mechanisms of 
this analgesic effect.
This pilot study had some limitations. The low incidence 
of PV did not allow a control group to be included in the 
study, so the potential placebo effect of the procedure 
could not be could not be excluded completely. In this 
pilot study, the pain of the patients was followed up for 
four days. We recommend that further studies (if possi-
ble as RCTs) consider larger sample sizes and extending 
the follow-up periods. In addition we recommend that in 
further studies the pain relieving effects of NTCLT and 
conventional low power lasers (such as diode lasers) be 
compared with each other in oral lesions of PV. 
Although in this trial we used eye glasses matched to the 
CO2 laser wavelength (10 600 nm), we highly recommend 
the application of eye glasses matched to both the 10 600 
nm and the guiding beam for eye protection against the 
reflected beam from the gel surface
In conclusion, the results of this trial proposed that NT-
CLT can be potentially considered as a novel alternative 
option for pain relief in oral lesions of PV. However the 
patients should continue their conventional treatment 
of PV, and understand that this pain relieving procedure 
cannot substitute the systemic treatment of the disease. 
This laser-based technique can improve both the patient’s 
oral intake (food and medication), and their quality of life, 
the concepts which should be evaluated in further studies.
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